With the inclusion of the FHOD3 in cardiomyopathy gene panels, the prevalence of FHOD3-associated HCM could be significantly higher than currently estimated, particularly among patients with HCM with Balkan ancestry. This evidence concerns the gene FHOD3 and cardiomyopathy.